ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

NCI RFA: Tobacco Use Research Centers

December 18, 1998

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

Also STAR trial can be completed with fewer women than planned, NSABP says.

November 7, 2003